Skip to content
S8633Senate2023-2024 Session

Notify Patients of Generic Swaps

Official title

“Requires notification by a prescriber or pharmacist of the substitution of one generic drug product for another generic drug product”

Sponsor Iwen ChuSD-17Affects Education
Status
In Senate Committee
Higher Education
Impact
4/10
Low
Passage
0%

Bill progress

Step 2 of 7

In committee · Higher Education

What's happening

This bill requires prescribers or pharmacists to notify patients, both in writing and orally, when substituting one generic drug for another.

Why it matters

  1. Enhances patient awareness and safety. By requiring both written and oral notification when a different generic drug is substituted, patients are more likely to notice changes in their medication, reducing the risk of confusion, missed doses, or adverse reactions due to unexpected differences in appearance or formulation.

  2. Encourages better communication between patients and healthcare providers. The dual notification process fosters more transparent, proactive conversations about medication changes, empowering patients to ask questions or raise concerns about new generics they receive.

  3. Helps patients manage chronic conditions more effectively. For those taking long-term medications, being promptly informed about substitutions can help them track side effects, efficacy, and ensure continuity of care, especially if they notice any changes after switching generics.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • Patients taking generic drugs

    They would receive both written and oral notice when prescribed or given a different generic drug product from the one they previously received.

  • Pharmacists

    They would be responsible for informing patients, both in writing and orally, when substituting a different generic drug product.

  • Prescribers

    They would be responsible for informing patients, both in writing and orally, when prescribing a different generic drug product from the one the patient previously received.

Headline styles

Notify Patients of Generic Swaps

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Iwen Chu

Senator · Senate District 17

Chair, Libraries

No co-sponsors yet.

History

  1. Referred to higher education

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

8633

IN SENATE

February 23, 2024

Introduced by Sen. CHU -- read twice and ordered printed, and when printed to be committed to the Committee on Higher Education

AN ACT to amend the education law, in relation to notification of the substitution of one generic drug product for another generic drug

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subdivision 6 of section 6810 of the education law is amended by adding a new paragraph (b-1) to read as follows:

(b-1) The prescriber or pharmacist shall inform the patient whether he or she has prescribed or substituted a different generic drug product from the generic drug product the patient has previously received. Notification required pursuant to this paragraph shall be provided both written and orally.

§ 2. This act shall take effect on the ninetieth day after it shall have become a law.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD14465-01-4

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the education law, in relation to notification of the substitution of one generic drug product for another generic drug

Purpose or general idea of bill

Requires a prescriber o pha farmcist to notify a patient if the generic drug has changed from aeciously used generic drug.

Summary of specific provisions

Section. 1 establishes the requirement to notify a patient orally and writing if their generic drug has changed.

Section 2 provides thatact shall take effect 90 days after enactment.

Justification

Not all generic drugs are the same. Although provisions requiring a pharmacist to notify a patient when their prescription has been filled by a generic equivalent exist, a pharmacist is not obligated to notify a patient if their prescription is filled with a different generic drug then they have been receiving. The change in pill shape, form, color, and potential effectiveness may cause, at minimum, confusion for patients, and at worst over/under dosing requiring emergency medical assistance. This bill seeks to better inform patients of changes to their prescription drugs.

Prior legislative history

2015-16 A.4605 Referred to highher Education; No Same As

2017-18 A. 3669 Referred to Higher Education; No Same As

2019-20 A.5143 Referred to Higher Education; No Same As

2020-21 A.3575 Referred to Higher Education; No Same As

Fiscal implications

None

Effective date

This act shall take effect 90 days after signed ir

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.